As the SVP of Client Relations at Media Bridge, I spend my days straddling two very different worlds. On one side, I look after fast-paced consumer retail and service brands. On the other, our MB Health arm specializes in the highly regulated, deeply complex environment of medtech and life sciences.
While quite different in many ways, both feel pressured to compress campaign launch timelines. The temptation to bypass the audience insight phase usually stems from two well-intentioned but flawed arguments: “We don’t have the budget for research right now,” or “We need this media live yesterday to hit our goals.”
However, analyzing campaign performance data reveals a striking reality: skipping due diligence doesn’t save time or money. It simply defers those costs into possibly fractured messaging, and/or longer optimization cycles down the road. It is the old adage in action: an ounce of prevention is worth a pound of cure.
The Spectrum of Strategic Insight
Proper due diligence before a campaign launch is not a rigid, academic exercise. It is a scale that we adapt to the complexity of the market, the product, and the target audience.
- The Lighter Lift (Desk Research & Behavioral Auditing): For more straightforward, “on the nose” consumer or retail industries, due diligence can be executed in a matter of days. This involves aggregate data analysis, competitive messaging audits, and digital behavioral tracking to align creative assets with active consumer intent.
- The Heavier Lift (Primary Qual/Quant Research): For complex ecosystems like medical devices, where the buyer journey involves physicians, procurement officers, and hospital IT gatekeepers. Due diligence requires a deeper operational investment. This means executing targeted stakeholder recruitment, blind panels, quantitative validation surveys, and deep-dive qualitative interviews to find out why buyers actually reject a solution.
The True Cost of Rushing the Launch
Deploying media based on commonly held beliefs and optimizing based on initial ad performance satisfies the immediate urge for action, but the resulting costs can be severe.
“Saving” Money:
Spending zero dollars on research and thousands on a media plan that misses the emotional or institutional friction points of your buyer results in a direct financial loss. Conversely, allocating a fraction of that budget to research ensures the remaining media spend is well-targeted and highly trackable/allocatable.
“Saving” Time:
The Time-to-Market Paradox: Impatience often drives brands to skip research to save time. But when a campaign fails to convert, teams spend months diagnosing where it is falling short – was the failure caused by the creative, the audience targeting, the landing page, or the product value proposition itself? Research upfront compresses the time it takes to achieve profitable traction.
The primary obstacle to pre-campaign research is the belief that insights take months to gather. In the modern business landscape, slow research is dead research. Taking too long (analysis paralysis) causes brands to miss their commercial window entirely. The goal should always be to uncover valuable insights at the speed of modern business. Already have the baseline research completed? Let’s take a look!
“The Best Strategy Is To Care”
This saying is not just the mural on our wall when you enter our offices, it’s how we approach every campaign, without exception. And this is why whether a brand arrives with fully completed primary research and mapped-out patient pathways, or requires custom-built qual/quant research from scratch, the entry criteria for a successful campaign remains unchanged: data must dictate the creative and tactical plan. Prioritizing insight over immediate execution is not “fluff”, it is the highest form of fiscal responsibility and the truest extension of what it means to care.
#TheBestStrategyIsToCare #MediaBridge #MarketingStrategy #MarketResearch #DataDriven #BusinessGrowth